ArrowMark Colorado Holdings’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
MFS
VP
CCM
MA
ArrowMark Colorado Holdings's MXCT Position: Q4 2025 in Review
ArrowMark Colorado Holdings sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 83,659 shares — an estimated $132K sold.
ArrowMark Colorado Holdings first reported a position in MXCT in Q3 2021 and held it in 17 quarters. The position peaked at $14.5M in Q3 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.
- ArrowMark Colorado Holdings reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
- ArrowMark Colorado Holdings sold 83,659 MaxCyte shares in Q4 2025, an estimated $132K.
- ArrowMark Colorado Holdings first reported a position in MaxCyte in Q3 2021 and held it in 17 quarters.
- ArrowMark Colorado Holdings's MaxCyte position peaked at $14.5M in Q3 2022.
- 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.
Based on ArrowMark Colorado Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.